Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Quantitative MRI After Conventional Transarterial Chemoembolization (cTACE) Help Predict Survival ?

NCT02173119 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT02173119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02173119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Quantitative MRI After Conventional Transarterial Chemoembolization (cTACE) Help Predict Survival ?
Lead sponsor
Medical College of Wisconsin
Phase
Observational
Overall status
Completed
Start date
August 31, 2014
Completion date
March 7, 2018
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc)